Phase II trial of encapsulated rapamycin to reduce polyp burden associated with familial adenomatous polyposis.
Saved in:
| Title: | Phase II trial of encapsulated rapamycin to reduce polyp burden associated with familial adenomatous polyposis. |
|---|---|
| Authors: | Broderick JC; San Antonio Uniformed Services Health Education Consortium San Antonio United States., Samadder NJ; Mayo Clinic Phoenix, AZ United States., Stoffel E; Michigan Medicine Ann Arbor, MI United States., Fang JC; University of Utah Hospital Salt Lake City, UT United States., Stanich PP; The Ohio State University Wexner Medical Center Columbus, OH United States., Wise P; Washington University Medical Center St. Louis, MO United States., Wright R; The University of Texas Health Science Center at San Antonio San Antonio, TX United States., Clifton T; San Antonio Military Medical Center Fort Sam Houston, TX United States., Peoples G; Cancer Vaccine Development Program San Antonio, Texas United States., Burke CA; Cleveland Clinic Cleveland, OH United States. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Apr 28. Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1557-3265 |
|---|---|
| DOI: | 10.1158/1078-0432.CCR-25-4126 |
